Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / GENOMICS AND BIO
-
Total 13F shares
-
313,294
-
Share change
-
+9,253
-
Total reported value
-
$14,241,700
-
Price per share
-
$45.46
-
Number of holders
-
39
-
Value change
-
+$629,342
-
Number of buys
-
13
-
Number of sells
-
22
Institutional Holders of GLOBAL X FDS - GENOMICS AND BIO (GNOM) as of Q4 2025
As of 31 Dec 2025,
GLOBAL X FDS - GENOMICS AND BIO (GNOM) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
313,294 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, LPL Financial LLC, OPPENHEIMER ASSET MANAGEMENT INC., FLOW TRADERS U.S. LLC, IHT Wealth Management, LLC, TWO SIGMA INVESTMENTS, LP, Stratos Wealth Partners, LTD., UBS Group AG, U.S. Capital Wealth Advisors, LLC, and JANE STREET GROUP, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.